44th week of 2016 patent applcation highlights part 9 |
Patent application number | Title | Published |
20160317411 | Method Employing Polyols When Chemically Modifying the Internal Region of a Hair Shaft | 2016-11-03 |
20160317412 | HAIR DYEING PROCESS USING AT LEAST ONE ORTHO-DIPHENOL AND ONE ORGANIC SALT OF TITANIUM AND OF A CARBOXYLIC ACID | 2016-11-03 |
20160317413 | HAIR DYEING METHOD EMPLOYING AT LEAST ONE ORTHO-DIPHENOL, ONE TITANIUM DERIVATIVE AND ONE CARBOXYLIC ACID | 2016-11-03 |
20160317414 | PREBIOTIC ORAL CARE METHODS USING A SACCHARIDE | 2016-11-03 |
20160317415 | Hair Straightening Method Involving Reducing Sugars | 2016-11-03 |
20160317416 | COSMETIC COMPOSITION COMPRISING AN OIL, A NONIONIC SURFACTANT AND A C-GLYCOSIDE COMPOUND | 2016-11-03 |
20160317417 | TRANSFER MAKEUP PROCESS AND RELATED DEVICE | 2016-11-03 |
20160317418 | METHOD OF IMPROVING THE APPEARANCE OF SKIN AND COMPOSITIONS THEREFOR | 2016-11-03 |
20160317419 | METHOD OF IMPROVING SKIN HEALTH AND COMPOSITIONS THEREFOR | 2016-11-03 |
20160317420 | METHOD OF IMPROVING THE APPEARANCE OF SKIN AND COMPOSITIONS THEREFOR | 2016-11-03 |
20160317421 | Optical Treatment Methods | 2016-11-03 |
20160317422 | FILM COMPOSITIONS FOR ORAL USE | 2016-11-03 |
20160317423 | DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM AND COSMETIC USE THEREOF | 2016-11-03 |
20160317424 | SUSPENSION AND STABILITY AGENT FOR ANTIDANDRUFF HAIR CARE COMPOSITIONS | 2016-11-03 |
20160317425 | COMPOUND, COMPOSITION, AND METHOD FOR PROTECTING SKIN FROM HIGH ENERGY VISIBLE LIGHT | 2016-11-03 |
20160317426 | COMPOSITION COMPRISING A SILICONE ELASTOMER, A SILICONE OIL, A PASTY FATTY SUBSTANCE AND AN APOLAR HYDROCARBON-BASED COMPOUND, AND USE AS AN ANTIMIGRATION COMPOSITION | 2016-11-03 |
20160317427 | POLYORGANOSILOXANE GELS HAVING POLYETHER GROUPS | 2016-11-03 |
20160317428 | Waxes Derived from Metathesized Natural Oils and Amines and Methods of Making | 2016-11-03 |
20160317429 | COMPOSITIONS COMPRISING LYSOZYME HYDROLYSATE FOR USE IN KERATIN-CONTAINING TISSUE | 2016-11-03 |
20160317430 | COSMETIC USE OF AN EXTRACT OF GYMNEMA SYLVESTRE | 2016-11-03 |
20160317431 | METHODS OF INHIBITING PAR2 ACTIVATION OF KERATINOCYTES AND METHODS OF MAKING COMPOSITIONS THEREFOR | 2016-11-03 |
20160317432 | Compositions And Methods For Improving Skin Health | 2016-11-03 |
20160317433 | PERSONAL CARE COMPOSITION CONTAINING YEAST/POLYPHENOL FERMENT EXTRACT | 2016-11-03 |
20160317434 | SELF-FUELED PARTICLES FOR PROPULSION THROUGH FLOWING AQUEOUS FLUIDS | 2016-11-03 |
20160317435 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORM OF SOLUTIONS OR SUSPENSIONS | 2016-11-03 |
20160317436 | Skin Repair Compound | 2016-11-03 |
20160317437 | EYE DROPS FOR TREATING DRY EYE | 2016-11-03 |
20160317438 | INJECTABLE SUSTAINED RELEASE INTRAOCULAR DEVICE | 2016-11-03 |
20160317439 | ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS | 2016-11-03 |
20160317440 | LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON | 2016-11-03 |
20160317441 | BIOMEMBRANE PHASE-CHANGE DROPLETS (PCD), DRUG CARRIER AND USE THEREOF | 2016-11-03 |
20160317442 | Nanosomal preparation of the complex formed by quercetin (or another flavonol, flavone or a derivative thereof) and 2-hydroxypropyl-beta-cyclodextrin for intravenous use in cerebral pathological conditions | 2016-11-03 |
20160317443 | HDL comprising a therapeutic agent and use in therapy | 2016-11-03 |
20160317444 | Liposomal Formulations for Allosteric AKT Inhibitors | 2016-11-03 |
20160317445 | DIALKYL SULFOSUCCINATE COMPOSITIONS, METHOD OF MAKING, AND METHOD OF USE | 2016-11-03 |
20160317446 | Compositions For Treating Acute, Post-Operative, Or Chronic Pain And Methods of Using The Same | 2016-11-03 |
20160317447 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING PAIN | 2016-11-03 |
20160317448 | EXTRUDED EXTENDED RELEASE ABUSE DETERRENT PILL | 2016-11-03 |
20160317449 | DOUBLE-LAYER TABLET AND PREPARATION METHOD THEREOF | 2016-11-03 |
20160317450 | AQUEOUS COMPOSITION FOR HARD CAPSULE, AND HARD CAPSULE PRODUCED USING SAME | 2016-11-03 |
20160317451 | AQUEOUS COMPOSITION FOR HARD CAPSULE, AND HARD CAPSULE PRODUCED USING SAME | 2016-11-03 |
20160317452 | Methods of Making and Using Nano Scale Particles | 2016-11-03 |
20160317453 | HIGH DRUG LOAD BUPRENORPHINE MICROSPHERES AND METHOD OF PRODUCING SAME | 2016-11-03 |
20160317454 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR MANUFACTURING THE SAME | 2016-11-03 |
20160317455 | NESTED PARTICLES AND THE USE THEREOF FOR COORDINATED DELVERY OF ACTIVE AGENTS | 2016-11-03 |
20160317456 | PHARMACEUTICAL COMPOSITIONS | 2016-11-03 |
20160317457 | Immediate Release Abuse-Deterrent Granulated Dosage Forms | 2016-11-03 |
20160317458 | Lipids and Lipid Compositions for the Delivery of Active Agents | 2016-11-03 |
20160317459 | NANOPARTICLE FORMULATIONS WITH ENHANCED MUCOSAL PENETRATION | 2016-11-03 |
20160317460 | NANO DELIVERY SYSTEMS FOR SIRNA | 2016-11-03 |
20160317461 | ELECTROSTATIC PRINTING OF CYCLODEXTRIN COMPOSITIONS | 2016-11-03 |
20160317462 | PHARMACEUTICAL MICROEMULSION IMMOBILIZED IN A THIN POLYMER MATRIX AND METHODS OF MAKING THEM | 2016-11-03 |
20160317463 | UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS | 2016-11-03 |
20160317464 | TRANSDERMAL METHODS AND SYSTEMS FOR THE DELIVERY OF ANTI-MIGRAINE COMPOUNDS | 2016-11-03 |
20160317465 | COVER MATERIAL-EQUIPPED PATCH AND COVER MATERIAL-EQUIPPED PATCH KIT | 2016-11-03 |
20160317466 | COMPOSITIONS COMPRISING TERPENE COMPOUNDS FOR TREATING NEGATIVE SENSORY PHENOMENA | 2016-11-03 |
20160317467 | METHOD OF TREATING OR PREVENTING INFECTION | 2016-11-03 |
20160317468 | USES OF CANNABIDIOL FOR TREATMENT OF INFANTILE SPASMS | 2016-11-03 |
20160317469 | Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same | 2016-11-03 |
20160317470 | AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES | 2016-11-03 |
20160317471 | USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME | 2016-11-03 |
20160317472 | Sphingosine Kinase Type 1 Inhibitors and Uses Thereof | 2016-11-03 |
20160317473 | METHODS OF TREATING OR PREVENTING BRAIN DAMAGE DUE TO HYPOXIC-ISCHEMIA | 2016-11-03 |
20160317474 | Managing Visual Dysfunction or Loss of Vision for Diabetic Subjects | 2016-11-03 |
20160317475 | COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFECTS | 2016-11-03 |
20160317476 | Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects | 2016-11-03 |
20160317477 | METHODS OF TREATING PRADER-WILLI SYNDROME | 2016-11-03 |
20160317478 | Biguanide Derivative, A Preparation Method Thereof, And A Pharmaceutical Composition Containing The Biguanide Derivative As An Active Ingredient | 2016-11-03 |
20160317479 | METHOD OF TREATING OR PREVENTING PAIN | 2016-11-03 |
20160317480 | Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness | 2016-11-03 |
20160317481 | USE OF AN OLEOGEL CONTAINING TRITERPENE FOR HEALING WOUNDS | 2016-11-03 |
20160317482 | Solid Solution Compositions and Use in Chronic Inflammation | 2016-11-03 |
20160317483 | COMBINATION OF BEZAFIBRATE AND OF RESVERATROL OR RESVERATROL DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DISEASES INVOLVING A MITOCHONDRIAL ENERGY DYSFUNCTION | 2016-11-03 |
20160317484 | Therapeutic Methods Employing Nitric Oxide Precursors | 2016-11-03 |
20160317485 | PROCESSES FOR OBTAINING MICROBIAL OIL FROM MICROBIAL CELLS | 2016-11-03 |
20160317486 | METHOD FOR WOUND HEALING | 2016-11-03 |
20160317487 | METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE | 2016-11-03 |
20160317488 | METHODS AND LIPID COMPOSITIONS FOR PROMOTING DEVELOPMENT OF GUT FLORA | 2016-11-03 |
20160317489 | Bicalutamide Analogs Or (S)-Bicalutamide As Exocytosis Activating Compounds For Use In The Treatment Of A Lysosomal Storage Disorder Or Glycogenosis | 2016-11-03 |
20160317490 | Taxane- and Taxoid-Protein Compositions | 2016-11-03 |
20160317491 | Artificial Tears Solution Combination | 2016-11-03 |
20160317492 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES CONTAINING FLUOXETINE AND VITAMIN C AS ACTIVE INGREDIENTS | 2016-11-03 |
20160317493 | Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Cystic Fibrosis | 2016-11-03 |
20160317494 | COMPOSITION COMPRISING TETRACYCLIC COMPOUND | 2016-11-03 |
20160317495 | PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATION | 2016-11-03 |
20160317496 | METHODS OF TREATING CANCER AND OTHER DISORDERS | 2016-11-03 |
20160317497 | FLAVORED ANALGESIC AND DECONGESTANT SPRAY | 2016-11-03 |
20160317498 | HALOFUGINONE ANALOGS FOR INHIBITION OF TRNA SYNTHETASES AND USES THEREOF | 2016-11-03 |
20160317499 | FGFR GATEKEEPER MUTANT GENE AND DRUG TARGETING SAME | 2016-11-03 |
20160317500 | NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS FOR THE PREVENTION AND TREATMENT OF KETOSIS | 2016-11-03 |
20160317501 | FUNGAL MYCOBIOME AS PROBIOTICS, DIAGNOSTICS AND THERAPEUTICS | 2016-11-03 |
20160317502 | USE OF ISOXAZOLINE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF ARTHROPOD INFESTATIONS IN POULTRY | 2016-11-03 |
20160317503 | ZOLMITRIPTAN POWDERS FOR PULMONARY DELIVERY | 2016-11-03 |
20160317504 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | 2016-11-03 |
20160317505 | NOVEL MODIFIED RELEASE DOSAGE FORMS OF XANTHINE OXIDOREDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS | 2016-11-03 |
20160317506 | PHARMACEUTICAL COMPOSITION CONTAINING A COMPOUND HAVING A THROMBOPOIETIN RECEPTOR AGONISTIC ACTIVITY | 2016-11-03 |
20160317507 | FORMS OF RIFAXIMIN AND USES THEREOF | 2016-11-03 |
20160317508 | Fused Amino Pyridines for the Treatment of Lung Cancer | 2016-11-03 |
20160317509 | MLK INHIBITORS AND METHODS OF USE | 2016-11-03 |
20160317510 | METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OX- O-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID IN COMBINATION THERAPY | 2016-11-03 |